Cargando…
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
Hypertension is a mechanism-based toxic effect of drugs that inhibit the vascular endothelial growth factor signaling pathway (VSP). Substantial evidence exists for managing hypertension as a chronic condition, but there are few prospectively collected data on managing acute hypertension caused by V...
Autores principales: | Maitland, Michael L., Bakris, George L., Black, Henry R., Chen, Helen X., Durand, Jean-Bernard, Elliott, William J., Ivy, S. Percy, Leier, Carl V., Lindenfeld, JoAnn, Liu, Glenn, Remick, Scot C., Steingart, Richard, Tang, W. H. Wilson |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864290/ https://www.ncbi.nlm.nih.gov/pubmed/20351338 http://dx.doi.org/10.1093/jnci/djq091 |
Ejemplares similares
-
Heart Failure Medical Therapy: A Review for Structural/Interventional Cardiologists
por: Pipilas, Alexandra, et al.
Publicado: (2022) -
Contemporary Management of Secondary Mitral Regurgitation
por: Goel, Kashish, et al.
Publicado: (2020) -
Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action
por: Neilan, Tomas G., et al.
Publicado: (2018) -
Chest Pain in a Psychiatric Patient Due to Clozapine-Induced Myopericarditis
por: Laws, James L., et al.
Publicado: (2021) -
EGFR inhibition in non-small cell lung cancer: current evidence and future directions
por: Chi, Alexander, et al.
Publicado: (2013)